Author Correction: Effect of disease modifying anti-rheumatic drugs on major cardiovascular events: a meta-analysis of randomized controlled trials
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Enregistré dans:
Auteurs principaux: | Shivshankar Thanigaimani, James Phie, Smriti Murali Krishna, Joseph Moxon, Jonathan Golledge |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7d828e3a20df4a67bf0f5dc28073699e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Effect of disease modifying anti-rheumatic drugs on major cardiovascular events: a meta-analysis of randomized controlled trials
par: Shivshankar Thanigaimani, et autres
Publié: (2021) -
Meta-Analysis of Asymmetric Dimethylarginine Concentrations in Rheumatic Diseases
par: Gian Luca Erre, et autres
Publié: (2019) - Rheumatic Fever & Rheumatic Heart Disease
-
Biomaker evaluation for major adverse cardiovascular event development in patients undergoing cardiac Surgery
par: Imperiali Claudia E., et autres
Publié: (2020) -
Residual Risk Factors to Predict Major Adverse Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with and without Diabetes Mellitus
par: Fang-Ju Lin, et autres
Publié: (2017)